Home › Pain After Surgery › NCT07400146
Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy
Instillation of Bupivacaine With Epinephrine Over Diaphragm to Reduce Postoperative Shoulder Pain Following Benign Gynecologic Laparoscopic Surgery: A Randomized Control Trial
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Provide a signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * 8 years of age or older * Undergoing laparoscopic surgery at Cedars-Sinai Medical Center with a surgeon in the Minimally Invasive Gynecologic Surgery division. Exclusion Criteria: * Pregnancy * Urgent/non-scheduled surgery * Scheduled for planned or possible concomitant non-gynecologic surgery (e.g., urologic or colorectal procedure) * Baseline shoulder pain * Baseline opioid use * Baseline of chronic pain syndrome * Conversion to open surgery * Allergy or intolerance to bupivacaine, lidocaine (or amide class of anesthetics), oxycodone, acetaminophen, or ibuprofen * Planned post-operative admission
About the study
Postoperative shoulder pain is often reported to be particularly bothersome after laparoscopy. The benefits of local anesthetic, such as bupivacaine, applied to subcutaneous tissue for general postoperative pain management after surgery is well established. However, there have been no studies on sprayed bupivacaine over the diaphragm to reduce shoulder pain in laparoscopic surgery. The purpose of the study is to evaluate if sprayed infra-diaphragmatic bupivacaine compared to placebo (saline) will improve postoperative shoulder pain in patients undergoing benign laparoscopic gynecologic surgery. The entire study will be conducted at Cedar Sinai Medical Center.
What is being tested
- Instillation of Bupivacaine with epinephrine over the diaphragm (drug)
Sponsor: Cedars-Sinai Medical Center · Participants: 100 · Started: Mar 2, 2026
Contact the study team
- Ogechukwu Ezike, MD · Phone: 3473371181
Official record on ClinicalTrials.gov — NCT07400146
Locations in the U.S.
| California | Cedars Sinai Medical Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.